المؤلفون: Franke, Klara, Foller, Susan, Rosero Moreno, Michele Estephania, Ali, Nalyan, Leistritz, Lutz, Leucht, Katharina, Grimm, Marc-Oliver

المساهمون: Yakirevich, Evgeny, Araújo, António

مصطلحات موضوعية: article, ScholarlyArticle, ddc:610, immune-related adverse events, side effects, immune-checkpoint inhibitors, renal cell carcinoma, immune therapy, lab values

وصف الملف: 14 Seiten

Relation: Cancers -- Cancers (Basel) -- 2072-6694 -- 2527080-1 -- http://uri.gbv.de/document/gvk:ppn:614095670; https://doi.org/10.3390/cancers16122287

الاتاحة: https://doi.org/10.3390/cancers16122287
https://nbn-resolving.org/urn:nbn:de:gbv:27-dbt-62070-6
https://www.db-thueringen.de/receive/dbt_mods_00062070
https://www.db-thueringen.de/servlets/MCRZipServlet/dbt_derivate_00064441

Alternate Title: Enfortumab vedotin and pembrolizumab: Management of side effects during first line combined treatment for advanced or metastatic urothelial carcinoma. (English)

المؤلفون: Retz, Margitta, Grimm, Marc-Oliver, Leucht, Katharina, Zschäbitz, Stefanie

المصدر: Die Urologie; Jan2025, Vol. 64 Issue 1, p60-74, 15p

المؤلفون: McKay, Rana R, Leucht, Katharina, Xie, Wanling, Jegede, Opeyemi, Braun, David A, Atkins, Michael B, Grimm, Marc-Oliver, Choueiri, Toni K

المساهمون: Bristol-Myers Squibb

المصدر: The Oncologist ; volume 29, issue 4, page 324-331 ; ISSN 1083-7159 1549-490X

الاتاحة: http://dx.doi.org/10.1093/oncolo/oyad298
https://academic.oup.com/oncolo/article-pdf/29/4/324/57210351/oyad298.pdf

المؤلفون: Grimm, Marc-Oliver, Esteban, Emilio, Barthélémy, Philippe, Schmidinger, Manuela, Busch, Jonas, Valderrama, Begoña P, Charnley, Natalie, Schmitz, Marc, Schumacher, Ulrike, Leucht, Katharina, Foller, Susan, Baretton, Gustavo, Duran, Ignacio, de Velasco, Guillermo, Priou, Frank, Maroto, Pablo, Albiges, Laurence, Barone, Carlo, Castellano, Daniel, Chevreau, Christine, Gajate Borau, Pablo, Gopalakrishnan, Srinavasan, Grande, Enrique, Hamid, Abdel, Heinzelbecker, Julia, Janssen, Martin, Kopecký, Jindřich, Kubala, Eugen, Loidl, Wolfgang, Lorch, Anja, Melichar, Bohuslav, Lainez Milagro, Nuria, Niegisch, Günter, Ohlmann, Carsten, Sacré, Anne, Sarwar, Naveed, Schinzari, Giovanni, Schrijvers, Dirk, Tartas, Sophie, Wirth, Manfred, Wolter, Pascal, Zemanova, Milanda

المساهمون: BMS, AIO-Studien, Bristol-Myers Squibb

المصدر: The Lancet Oncology ; volume 24, issue 11, page 1252-1265 ; ISSN 1470-2045

الاتاحة: https://doi.org/10.1016/s1470-2045(23)00449-7
https://api.elsevier.com/content/article/PII:S1470204523004497?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1470204523004497?httpAccept=text/plain

المؤلفون: Frölich, Ute Maria^1,2 (AUTHOR) ute-froelich@web.de, Leucht, Katharina^1,2 (AUTHOR) katharina.leucht@med.uni-jena.de, Grimm, Marc-Oliver^1,2 (AUTHOR), Foller, Susan^1,2 (AUTHOR) susan_voigt@gmx.net

المصدر: Cancers. Oct2024, Vol. 16 Issue 20, p3523. 13p.

مصطلحات موضوعية: *THROMBOSIS surgery, *VENA cava inferior, *RISK assessment, *NEPHRECTOMY, *RETROSPECTIVE studies, *DESCRIPTIVE statistics, *CHI-squared test, *MANN Whitney U Test, *BLOOD-vessel tumors, *SURGICAL complications, *RENAL cell carcinoma, *MEDICAL records, *ACQUISITION of data, *THROMBECTOMY, *COMPARATIVE studies, *DISEASE risk factors

المؤلفون: Schomburg, Laura, Malouhi, Amer, Grimm, Marc-Oliver, Ingwersen, Maja, Foller, Susan, Leucht, Katharina, Teichgräber, Ulf

مصطلحات موضوعية: article, ScholarlyArticle, ddc:610, Immunotherapy, Disease progression, Renal cell carcinoma, Response evaluation criteria in solid tumors, Tumor burden

وصف الملف: 10 Seiten

Relation: Journal of Cancer Research and Clinical Oncology -- 0171-5216 -- 1432-1335

الاتاحة: https://doi.org/10.1007/s00432-022-03997-0
https://nbn-resolving.org/urn:nbn:de:gbv:27-dbt-62994-6
https://www.db-thueringen.de/receive/dbt_mods_00062994
https://www.db-thueringen.de/servlets/MCRFileNodeServlet/dbt_derivate_00065241/s00432-022-03997-0.pdf

المؤلفون: Leucht, Katharina, Ali, Nalyan, Foller, Susan, Grimm, Marc-Oliver

المساهمون: Dormoy, Valerian, Barthélémy, Philippe, Massfelder, Thierry, Garige, Mamatha

مصطلحات موضوعية: article, ScholarlyArticle, ddc:610, immune-related adverse events, side effects, immune-checkpoint inhibitors, renal cell carcinoma, immune therapy, adverse reactions

وصف الملف: 12 Seiten

Relation: Cancers -- Cancers (Basel) -- 2072-6694 -- 2527080-1 -- http://uri.gbv.de/document/gvk:ppn:614095670; https://doi.org/10.3390/cancers14184369

الاتاحة: https://doi.org/10.3390/cancers14184369
https://www.db-thueringen.de/receive/dbt_mods_00053657
https://www.db-thueringen.de/servlets/MCRFileNodeServlet/dbt_derivate_00057462/cancers-14-04369.pdf

المؤلفون: Grimm, Marc-Oliver, Schostak, Martin, Grün, Christine Barbara, Loidl, Wolfgang, Pichler, Martin, Zimmermann, Uwe, Schmitz-Dräger, Bernd, Steiner, Thomas, Roghmann, Florian, Niegisch, Günter, Bolenz, Christian, Schmitz, Marc, Baretton, Gustavo, Leucht, Katharina, Schumacher, Ulrike, Foller, Susan, Zengerling, Friedemann, Meran, Johannes

المصدر: JAMA Oncology; Jun2024, Vol. 10 Issue 6, p755-764, 10p

المؤلفون: Foller, Susan, Leucht, Katharina, Grimm, Marc-Oliver

المصدر: TumorDiagnostik & Therapie ; volume 45, issue 02, page 85-89 ; ISSN 0722-219X 1439-1279

الاتاحة: http://dx.doi.org/10.1055/a-1980-7699
http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1980-7699.pdf

المؤلفون: Grimm, Marc-Oliver, Leucht, Katharina, Foller, Susan

المساهمون: Novara, Giacomo

مصطلحات موضوعية: article, ScholarlyArticle, ddc:610, renal cell carcinoma, immune-checkpoint inhibitors, axitinib, avelumab, nivolumab, ipilimumab, pembrolizumab, cabozantinib

وصف الملف: 12 Seiten

Relation: Journal of Clinical Medicine -- 2077-0383 -- http://uri.gbv.de/document/gvk:ppn:718632478 -- 2662592-1 -- http://www.bibliothek.uni-regensburg.de/ezeit/?2662592 -- http://www.mdpi.com/journal/jcm -- https://www.ncbi.nlm.nih.gov/pmc/journals/2745/; https://doi.org/10.3390/jcm10225339; http://uri.gbv.de/document/gvk:ppn:1786226170

الاتاحة: https://doi.org/10.3390/jcm10225339
https://nbn-resolving.org/urn:nbn:de:gbv:27-dbt-20220128-143726-000
https://www.db-thueringen.de/receive/dbt_mods_00051267
https://www.db-thueringen.de/servlets/MCRFileNodeServlet/dbt_derivate_00055545/jcm-10-05339.pdf
http://uri.gbv.de/document/gvk:ppn:1786226170

المؤلفون: Grimm, Marc-Oliver, Gottschlich, Tobias, Ali, Nalyan, Foller, Susan, Leucht, Katharina

المصدر: Der Urologe ; ISSN 0340-2592 1433-0563

الاتاحة: https://doi.org/10.1007/s00120-021-01590-w
https://link.springer.com/content/pdf/10.1007/s00120-021-01590-w.pdf
https://link.springer.com/article/10.1007/s00120-021-01590-w/fulltext.html

المؤلفون: Grimm, Marc-Oliver, Leucht, Katharina

المصدر: European Urology Open Science ; volume 33, page 81-82 ; ISSN 2666-1683

الاتاحة: http://dx.doi.org/10.1016/j.euros.2021.09.001
https://api.elsevier.com/content/article/PII:S2666168321006704?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S2666168321006704?httpAccept=text/plain

المؤلفون: McKay, Rana R, Leucht, Katharina, Xie, Wanling, Jegede, Opeyemi, Braun, David A, Atkins, Michael B, Grimm, Marc-Oliver, Choueiri, Toni K

المصدر: Oncologist; Apr2024, Vol. 29 Issue 4, p324-331, 8p

مصطلحات موضوعية: RESEARCH funding, SALVAGE therapy, CLINICAL trials, IMMUNOTHERAPY, FISHER exact test, CANCER patients, DESCRIPTIVE statistics, CHI-squared test, LOG-rank test, KAPLAN-Meier estimator, RENAL cell carcinoma, NIVOLUMAB, PROGRESSION-free survival, CONFIDENCE intervals, IPILIMUMAB, OVERALL survival, DISEASE progression

المؤلفون: Grimm, Marc-Oliver, Leucht, Katharina, Grünwald, Viktor, Foller, Susan

مصطلحات موضوعية: article, ScholarlyArticle, ddc:610, renal cell carcinoma, immune checkpoint inhibitors, axitinib, avelumab, nivolumab, ipilimumab, pembrolizumab

وصف الملف: 9 Seiten

Relation: Journal of Clinical Medicine -- 2077-0383; https://doi.org/10.3390/jcm9020565

الاتاحة: https://doi.org/10.3390/jcm9020565
https://www.db-thueringen.de/receive/dbt_mods_00040922
https://www.db-thueringen.de/servlets/MCRFileNodeServlet/dbt_derivate_00046779/jcm-09-00565.pdf

Alternate Title: Combination therapy with poly(adenosine diphosphate-ribose) polymerase (PARPi) and androgen receptor signaling pathway (ARPi) inhibitors for metastatic castration-resistant prostate cancer. (English)

المؤلفون: Grimm, Marc-Oliver, Foller, Susan, Leucht, Katharina

المصدر: Die Urologie; Dec2023, Vol. 62 Issue 12, p1269-1280, 12p

مصطلحات موضوعية: HORMONE therapy, METASTASIS, ANTINEOPLASTIC agents, CASTRATION-resistant prostate cancer, CELLULAR signal transduction, ANDROGEN receptors, PHARMACODYNAMICS

المؤلفون: Grimm, Marc-Oliver, Foller, Susan, Leeder, Mirjam, Leucht, Katharina

المصدر: Die Urologie ; volume 62, issue 10, page 1095-1095 ; ISSN 2731-7064 2731-7072

الاتاحة: https://doi.org/10.1007/s00120-023-02178-2
https://link.springer.com/content/pdf/10.1007/s00120-023-02178-2.pdf
https://link.springer.com/article/10.1007/s00120-023-02178-2/fulltext.html

المؤلفون: Grimm, Marc-Oliver, Foller, Susan, Leeder, Mirjam, Leucht, Katharina

المصدر: Die Urologie ; volume 62, issue 7, page 679-684 ; ISSN 2731-7064 2731-7072

الاتاحة: http://dx.doi.org/10.1007/s00120-023-02118-0
https://link.springer.com/content/pdf/10.1007/s00120-023-02118-0.pdf
https://link.springer.com/article/10.1007/s00120-023-02118-0/fulltext.html

المؤلفون: Grimm, Marc-Oliver, Grün, Christine Barbara, Niegisch, Günter, Pichler, Martin, Roghmann, Florian, Schmitz-Dräger, Bernd, Baretton, Gustavo, Schmitz, Marc, Bolenz, Christian, Foller, Susan, Leucht, Katharina, Schumacher, Ulrike, Schostak, Martin, Meran, Johannes, Loidl, Wolfgang, Zengerling, Friedemann

المساهمون: AIO-Studien, Bristol-Myers Squibb

المصدر: The Lancet Oncology ; volume 24, issue 4, page 347-359 ; ISSN 1470-2045

الاتاحة: http://dx.doi.org/10.1016/s1470-2045(23)00053-0
https://api.elsevier.com/content/article/PII:S1470204523000530?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1470204523000530?httpAccept=text/plain

المؤلفون: Wang, Yu, de Vallière, Cheryl, Imenez Silva, Pedro H, Leonardi, Irina, Gruber, Sven, Gerstgrasser, Alexandra, Melhem, Hassan, Weber, Achim, Leucht, Katharina, Wolfram, Lutz, Hausmann, Martin, Krieg, Carsten, Thomasson, Koray, Boyman, Onur, Frey-Wagner, Isabelle, Rogler, Gerhard, Wagner, Carsten A

المصدر: Wang, Yu; de Vallière, Cheryl; Imenez Silva, Pedro H; Leonardi, Irina; Gruber, Sven; Gerstgrasser, Alexandra; Melhem, Hassan; Weber, Achim; Leucht, Katharina; Wolfram, Lutz; Hausmann, Martin; Krieg, Carsten; Thomasson, Koray; Boyman, Onur; Frey-Wagner, Isabelle; Rogler, Gerhard; Wagner, Carsten A (2018). The proton-activated receptor GPR4 modulates intestinal inflammation. Journal of Crohn's & Colitis, 12(3):355-368.

مصطلحات موضوعية: Clinic for Immunology, Institute of Physiology, Clinic for Gastroenterology and Hepatology, 610 Medicine & health

وصف الملف: application/pdf

Relation: https://www.zora.uzh.ch/id/eprint/144879/1/144879.pdf; info:pmid/29136128; urn:issn:1873-9946

الاتاحة: https://www.zora.uzh.ch/id/eprint/144879/
https://www.zora.uzh.ch/id/eprint/144879/1/144879.pdf

المؤلفون: Wang, Yu, de Vallière, Cheryl, Imenez Silva, Pedro H, Leonardi, Irina, Gruber, Sven, Gerstgrasser, Alexandra, Melhem, Hassan, Weber, Achim, Leucht, Katharina, Wolfram, Lutz, Hausmann, Martin, Krieg, Carsten, Thomasson, Koray, Boyman, Onur, Frey-Wagner, Isabelle, Rogler, Gerhard, Wagner, Carsten A

المساهمون: Seventh Framework Programme, Conselho Nacional de Desenvolvimento Científico e Tecnológico

المصدر: Journal of Crohn's and Colitis ; volume 12, issue 3, page 355-368 ; ISSN 1873-9946 1876-4479

الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjx147
http://academic.oup.com/ecco-jcc/article-pdf/12/3/355/27097335/jjx147.pdf